These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12072590)

  • 1. Can biochemical markers be used to screen patients with inflammatory bowel disease for osteoporosis?
    Compston JE
    Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):587-9. PubMed ID: 12072590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for osteoporosis in patients with inflammatory bowel disease by using urinary N-telopeptides.
    Bregenzer N; Erban P; Albrich H; Schmitz G; Feuerbach S; Schölmerich J; Andus T
    Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):599-605. PubMed ID: 12072593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: Osteoporosis and inflammatory bowel disease.
    Bernstein CN; Leslie WD
    Aliment Pharmacol Ther; 2004 May; 19(9):941-52. PubMed ID: 15113361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory bowel disease and the risk of osteoporosis and fracture.
    Targownik LE; Bernstein CN; Leslie WD
    Maturitas; 2013 Dec; 76(4):315-9. PubMed ID: 24139749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on osteoporosis in pediatric inflammatory bowel disease.
    Harpavat M; Keljo DJ
    Curr Gastroenterol Rep; 2003 Jun; 5(3):225-32. PubMed ID: 12734045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased fracture risk and osteoporosis not associated with vitamin D levels in Malaysian patients with inflammatory bowel disease.
    Hilmi I; Sunderesvaran K; Ananda V; Sarji SA; Arumugam K; Goh KL
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2415-21. PubMed ID: 23553858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Osteodensitometry in children and adolescents with inflammatory bowel disease].
    Kluge G; Borte M; Richter T; Kahn T; Borte G
    Rofo; 2007 Jan; 179(1):58-64. PubMed ID: 17203445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of osteoporosis in patients with inflammatory bowel disease.
    Compston JE
    Eur J Gastroenterol Hepatol; 1997 Oct; 9(10):931-3. PubMed ID: 9391779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment.
    Katz S
    Rev Gastroenterol Disord; 2006; 6(2):63-71. PubMed ID: 16699475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inflammatory bowel disease and bone decreased bone mineral density].
    Hisamatsu T; Wada Y; Kanai T
    Clin Calcium; 2015 Nov; 25(11):1639-44. PubMed ID: 26503868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The risk factor for low bone mineral density in patients with inflammatory bowel disease].
    Liu JB; Gao X; Zhang FB; Yang L; Xiao YL; Zhang RD; Li ZP; Hu PJ; Chen MH
    Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):833-6. PubMed ID: 20079225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of bone mineral density in patients with inflammatory bowel disease.
    Cuffari C; Lichtenstein GR
    Curr Gastroenterol Rep; 2003 Aug; 5(4):261-2. PubMed ID: 12864952
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
    Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
    Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone loss in patients with inflammatory bowel disease is less than expected: a follow-up study.
    Schulte C; Dignass AU; Mann K; Goebell H
    Scand J Gastroenterol; 1999 Jul; 34(7):696-702. PubMed ID: 10466881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study.
    Garnero P; Sornay-Rendu E; Claustrat B; Delmas PD
    J Bone Miner Res; 2000 Aug; 15(8):1526-36. PubMed ID: 10934651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency of osteoporosis screening in men with inflammatory bowel disease.
    Nguyen HD; Bakshi AK; Borum ML
    Am J Mens Health; 2010 Mar; 4(1):71-4. PubMed ID: 19477762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease.
    Schulte C; Dignass AU; Mann K; Goebell H
    Inflamm Bowel Dis; 1998 Nov; 4(4):268-75. PubMed ID: 9836078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease.
    Lamb EJ; Wong T; Smith DJ; Simpson DE; Coakley AJ; Moniz C; Muller AF
    Aliment Pharmacol Ther; 2002 Nov; 16(11):1895-902. PubMed ID: 12390098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and management of osteoporosis in inflammatory bowel disease.
    Targownik LE; Bernstein CN; Leslie WD
    Curr Opin Gastroenterol; 2014 Mar; 30(2):168-74. PubMed ID: 24419292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
    Firouzi F; Rashidi M; Hashemi S; Kangavari M; Bahari A; Daryani NE; Emam MM; Naderi N; Shalmani HM; Farnood A; Zali M
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1075-81. PubMed ID: 17998832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.